Initial Management of Acute CHF in Elderly Patients
Begin immediate IV loop diuretics (furosemide 40 mg IV if diuretic-naïve, or double the home oral dose if already on diuretics) within 60 minutes of presentation, combined with IV vasodilators (nitroglycerin or nitroprusside) if systolic blood pressure exceeds 110 mmHg. 1, 2
Immediate Assessment and Triage (First 10 Minutes)
Rapidly assess severity to determine level of care:
High-risk features requiring ICU/CCU admission: respiratory rate >25/min, SpO2 <90% despite oxygen, systolic BP <90 mmHg, use of accessory breathing muscles, altered mental status, or signs of hypoperfusion (cold peripheries, oliguria, lactate >2 mmol/L) 1
Moderate-risk patients without these features can be managed in monitored ward settings with cardiology consultation 1
Initiate continuous monitoring (pulse oximetry, blood pressure, ECG, respiratory rate) immediately upon patient contact 1
Respiratory Support
Provide oxygen therapy if SpO2 <90%, but avoid hyperoxia 1
Start non-invasive ventilation (CPAP or BiPAP) immediately in patients with respiratory distress, as this reduces intubation rates and may reduce mortality 1
- CPAP is simpler and feasible even in pre-hospital settings 1
- Continue NIV on hospital arrival if respiratory distress persists 1
Pharmacological Management Based on Blood Pressure
For SBP >110 mmHg (Most Elderly Patients)
First-line: IV vasodilators PLUS IV diuretics 1
- IV nitroglycerin or nitroprusside should be started early, as delayed administration is associated with higher mortality 1
- IV furosemide: Start with 40 mg IV bolus if diuretic-naïve, or at least double the chronic oral dose if already on diuretics 1, 2
Monitor diuretic response aggressively:
- After 2 hours: Check spot urinary sodium (target ≥50-70 mmol/L) 2
- After 6 hours: Assess urine output (target ≥100-150 mL/hour) 2
- If targets not met: Double the diuretic dose, up to 400-600 mg furosemide daily (up to 1000 mg in severe renal dysfunction) 2
Consider early combination diuretic therapy (within first 24-48 hours) by adding acetazolamide 500 mg IV once daily, particularly if baseline bicarbonate ≥27 mmol/L, but limit use to first 3 days to prevent metabolic disturbances 2
For SBP <110 mmHg
Diuretics remain first-line therapy, but avoid vasodilators 1
- Use furosemide cautiously at lower initial doses 1
- Do NOT routinely use inotropes (dobutamine) or vasopressors unless signs of cardiogenic shock or persistent hypoperfusion despite adequate filling status 1
Special Considerations for Elderly Patients
Thiazide diuretics are often ineffective due to reduced GFR; use loop diuretics instead 1
Monitor closely for hyperkalemia when combining ACE inhibitors/ARBs with aldosterone antagonists, especially in presence of renal dysfunction 1, 3
Avoid routine morphine use - while it may relieve dyspnea, it is associated with higher rates of mechanical ventilation, ICU admission, and death in registry data 1
Address precipitating factors immediately: atrial fibrillation, myocardial ischemia, hypertension, anemia, thyroid dysfunction, medication non-adherence, or excessive preload reduction from over-diuresis 1, 3
Critical Monitoring Parameters
Recheck within 2-6 hours:
Within 24-48 hours:
- Renal function (creatinine, BUN) and electrolytes (potassium, sodium, bicarbonate) 1, 2
- BNP/NT-proBNP levels 1
- Signs of residual congestion (edema, rales, elevated JVP) 2, 4
Pitfalls to Avoid
Do not discharge patients with residual congestion - this is associated with poor prognosis and high readmission rates 2, 4
Avoid excessive preload reduction - elderly patients with diastolic dysfunction are particularly sensitive to over-diuresis, which can paradoxically reduce stroke volume and cardiac output 1, 5
Do not withhold beta-blockers solely due to age - they reduce mortality in elderly patients ≥65 years, though contraindications (sick sinus syndrome, AV block, severe COPD) must be excluded 1, 6
Adjust digoxin dosing for renal function - elderly patients are more susceptible to digoxin toxicity; start with low doses when creatinine is elevated 1
Transition Planning
Schedule first follow-up within 10 days of discharge to assess medication tolerance, symptom improvement, and laboratory parameters 1, 3, 5
Initiate or optimize guideline-directed medical therapy before discharge (ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists) at low doses with plan for gradual titration 6, 3, 2